| An updated meta-analysis and system review: Is gemcitabine+fluoropyrimidine in combination a better therapy versus gemcitabine alone for advanced and unresectable pancreatic cancer? | |
| Tu C.; Zheng F.; Wang J.-Y.; Li Y.-Y.; Qian K.-Q. | |
| 刊名 | Asian Pacific Journal of Cancer Prevention
 |
| 2015 | |
| 卷号 | 16期号:14页码:5681-5686 |
| 关键词 | Capecitabine Fluorouracil Gemcitabine Meta-analysis Pancreatic cancer S-1 |
| DOI | 10.7314/APJCP.2015.16.14.5681 |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4776019 |
| 专题 | 山东大学 |
| 作者单位 | 1.Oncology Institute, The Affiliated Hospital of Nanjing Medical University, Changzhou No. 2 People's Hospital, Changzhou, China 2.Med |
| 推荐引用方式 GB/T 7714 | Tu C.,Zheng F.,Wang J.-Y.,et al. An updated meta-analysis and system review: Is gemcitabine+fluoropyrimidine in combination a better therapy versus gemcitabine alone for advanced and unresectable pancreatic cancer?[J]. Asian Pacific Journal of Cancer Prevention,2015,16(14):5681-5686. |
| APA | Tu C.,Zheng F.,Wang J.-Y.,Li Y.-Y.,&Qian K.-Q..(2015).An updated meta-analysis and system review: Is gemcitabine+fluoropyrimidine in combination a better therapy versus gemcitabine alone for advanced and unresectable pancreatic cancer?.Asian Pacific Journal of Cancer Prevention,16(14),5681-5686. |
| MLA | Tu C.,et al."An updated meta-analysis and system review: Is gemcitabine+fluoropyrimidine in combination a better therapy versus gemcitabine alone for advanced and unresectable pancreatic cancer?".Asian Pacific Journal of Cancer Prevention 16.14(2015):5681-5686. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论